belatacept

Known as: CD152 antigen, CTLA4-Ig 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2016
Highly Cited
2016
BACKGROUND In previous analyses of BENEFIT, a phase 3 study, belatacept-based immunosuppression, as compared with cyclosporine… (More)
Is this relevant?
Highly Cited
2012
Highly Cited
2012
Recipients of extended-criteria donor (ECD) kidneys have poorer long-term outcomes compared to standard-criteria donor kidney… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Current immunosuppressive regimens in renal transplantation typically include calcineurin inhibitors (CNIs) and corticosteroids… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Belatacept is a first-in-class co-stimulation blocker in development for primary maintenance immunosuppression. A Phase II study… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Recipients of extended criteria donor (ECD) kidneys are at increased risk for graft dysfunction/loss, and may benefit from… (More)
Is this relevant?
2010
2010
BACKGROUND Belatacept is associated with better renal function and an improved cardiovascular/metabolic risk profile versus… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
Is this relevant?
Highly Cited
2006
Highly Cited
2006
In this study, we propagated myeloid dendritic cells (DC) from BALB/c (H2(d)) mouse bone marrow progenitors in IL-10 and TGF-beta… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Current success in organ transplantation is dependent upon the use of calcineurin-inhibitor-based immunosuppressive regimens… (More)
Is this relevant?
2005
2005
BACKGROUND Renal transplantation is the standard of care for patients with end-stage renal disease. Although maintenance… (More)
Is this relevant?
Highly Cited
1997
Highly Cited
1997
Selective inhibition of T cell costimulation using the B7-specific fusion protein CTLA4-Ig has been shown to induce long-term… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?